NEW YORK, Dec. 19, 2025 /PRNewswire/ — Medome is the first AI technology for Personal Health Records for consumers. Patented and clinically validated with thousandsNEW YORK, Dec. 19, 2025 /PRNewswire/ — Medome is the first AI technology for Personal Health Records for consumers. Patented and clinically validated with thousands

Medome Launch Heralds the End of Medical Misdiagnoses and Lost Lives

2025/12/20 02:45
3 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

NEW YORK, Dec. 19, 2025 /PRNewswire/ — Medome is the first AI technology for Personal Health Records for consumers. Patented and clinically validated with thousands of real patients, it represents a groundbreaking approach to medical diagnostics, officially launching today to prevent misdiagnoses and improve patient outcomes. Created by physicians and technologists who have personally experienced the consequences of medical errors, Medome leverages advanced AI to bridge the gap between patients and the accurate healthcare they crave.

Medome arose from a tragic loss. Dr. Steven Charlap, a physician and entrepreneur, lost his brother to a preventable cancer medical diagnosis error. These preventable events underscore a devastating reality: nearly 400,000 people in the U.S. die each year due to errors in the diagnostic processes.

Driven by these experiences, the Medome team has harnessed the potential of AI to change the course of patient safety. “Medome exists so no one else dies again from misdiagnosis,” Dr. Charlap says, emphasizing that this platform was built to save lives through superior medical diagnostics.

Medome is not just another patient-facing symptom checker or a basic ai doctor; it is a comprehensive ai doctor diagnosis system. By utilizing sophisticated AI systems to organize, synthesize, and analyze personal information from lab results to family history Medome portrays a complete picture, uncovering patterns that often get missed.

Unlike other tools, Medome performs multiple intense calibrations in real time to narrow down possibilities. Dr. Charlap explains, “Medical knowledge now exceeds human intellectual capabilities. Our goal is not to replace human doctors but to enable patients to assist clinicians by being more contributory to their health journeys.” By using artificial intelligence as the bridge, the platform enhances decisions and identifies safety issues early when they are most effectively treated.

Medome represents a paradigm shift where enabled patients work alongside their providers. By applying proprietary methodologies to complex data, Medome which received support from Stanford, Harvard, the NIH, and the UK’s National Health Services enables patients to exert greater control over their diagnosis and treatment plan.

“We built Medome to save lives and ensure no one has to encounter a physician alone again,” Dr. Charlap concludes.

About Medome

Medome is an ai medical diagnosis and health intelligence platform that consolidates your medical history to provide a personalized treatment plan and prevent crises. It analyzes symptoms against your unique risk profile and distinguishes a local emergency from manageable problems. When you do need urgent care, it instantly generates a comprehensive medical summary to optimize diagnostic processes. Think of it as a medical command center that knows you better than any 15-minute appointment ever could.

Users can learn more at: www.medome.ai

Contact
Medome
media@medome.ai

Photo – https://mma.prnewswire.com/media/2849829/Medome_Logo.jpg

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/medome-launch-heralds-the-end-of-medical-misdiagnoses-and-lost-lives-302647184.html

SOURCE Medome

Market Opportunity
null Logo
null Price(null)
--
----
USD
null (null) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

The Best Crypto Presale in 2025? Solana and ADA Struggle, but Lyno AI Surges With Growing Momentum

The Best Crypto Presale in 2025? Solana and ADA Struggle, but Lyno AI Surges With Growing Momentum

The post The Best Crypto Presale in 2025? Solana and ADA Struggle, but Lyno AI Surges With Growing Momentum appeared on BitcoinEthereumNews.com. With the development of 2025, certain large cryptocurrencies encounter continuous issues and a new player secures an impressive advantage. Solana is struggling with congestion, and the ADA of Cardano is still at a significantly lower level than its highest price. In the meantime, Lyno AI presale is gaining momentum, attracting a large number of investors. Solana Faces Setbacks Amid Market Pressure However, despite the hype surrounding ETFs, Solana fell by 7% to $ 203, due to the constant congestion problems that hamper its network functionality. This makes adoption slow and aggravates traders who want to get things done quickly. Recent upgrades should combat those issues but the competition is rising, and Solana continues to lag in terms of user adoption and ecosystem development. Cardano Struggles to Regain Momentum ADA, the token of a Cardano, costs 72% less than the 2021 high and is developing more slowly than Ethereum Layer 2 solutions. The adoption of the coin is not making any progress despite the good forecasts. Analysts believe that the road to regain the past heights is long before Cardano can go back, with more technological advancements getting more and more attention. Lyno AI’s Explosive Presale Growth In stark contrast, Lyno AI is currently in its Early Bird presale, in which tokens are sold at 0.05 per unit and have already sold 632,398 tokens and raised 31,462 dollars. The next stage price will be established at $0.055 and the final target will be at $0.10. Audited by Cyberscope , Lyno AI provides a cross-chain AI arbitrage platform that enables retail traders to compete with institutions. Its AI algorithms perform trades in 15+ blockchains in real time, opening profitable arbitrage opportunities to everyone. Those who make purchases above 100 dollars are also offered the possibility of winning in the 100K Lyno AI…
Share
BitcoinEthereumNews2025/09/18 18:22
What to Look for in Professional Liability Insurance for Beauty Professionals

What to Look for in Professional Liability Insurance for Beauty Professionals

A career in the beauty is very rewarding but has its own perils on day to day basis. You are either a loyal cosmetologist or you are an esthetician; either way,
Share
Techbullion2026/03/07 18:09
Tether and Bitfinex Face Class Action Over Alleged Bitcoin and Ethereum Price Manipulation

Tether and Bitfinex Face Class Action Over Alleged Bitcoin and Ethereum Price Manipulation

The post Tether and Bitfinex Face Class Action Over Alleged Bitcoin and Ethereum Price Manipulation appeared first on Coinpedia Fintech News On 6 March 2026, the
Share
CoinPedia2026/03/07 18:16